ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BPMC Blueprint Medicines Corporation

99.79
4.74 (4.99%)
Feb 27 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Blueprint Medicines Corporation BPMC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
4.74 4.99% 99.79 20:00:00
Open Price Low Price High Price Close Price Prev Close
95.00 95.00 99.87 99.79 95.05
more quote information »

Recent News

Date Time Source Heading
2/27/202411:17IHNWFeaturedGlucotrack selects cirtec medical as manufacturer for its implantable continuous blood glucose monitor
2/23/202408:00PRNUSBlueprint Medicines Highlights AYVAKIT® (avapritinib)..
2/22/202408:20EDGAR2Form 8-K - Current report
2/16/202416:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/15/202417:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/15/202407:05EDGAR2Form 8-K - Current report
2/15/202407:00PRNUSBlueprint Medicines Reports Fourth Quarter and Full Year..
2/14/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202416:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
2/01/202408:00PRNUSBlueprint Medicines to Report Fourth Quarter and Full Year..
1/29/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202416:13EDGAR2Form 144 - Report of proposed sale of securities
1/08/202408:03EDGAR2Form 8-K - Current report
1/08/202408:00PRNUSBlueprint Medicines Highlights 2024 Corporate Strategy and..
1/05/202416:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
12/26/202316:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/22/202316:09EDGAR2Form 144 - Report of proposed sale of securities
12/19/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202308:00PRNUSBlueprint Medicines to Present at 42nd Annual J.P. Morgan..
12/15/202316:23EDGAR2Form 144 - Report of proposed sale of securities
12/13/202315:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202308:05PRNUSBlueprint Medicines' AYVAKYT® (avapritinib) Receives..
12/11/202317:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/09/202312:30PRNUSBlueprint Medicines' Leadership in Driving Continued..
12/07/202318:09EDGAR2Form 144 - Report of proposed sale of securities
12/06/202320:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202316:12EDGAR2Form 144 - Report of proposed sale of securities
12/04/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202316:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
11/28/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202308:00PRNUSBlueprint Medicines to Present at JMP Securities Hematology..
11/24/202313:17EDGAR2Form 144 - Report of proposed sale of securities
11/10/202308:00PRNUSBlueprint Medicines' AYVAKYT® (avapritinib) Receives..
11/03/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202316:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
10/30/202314:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/26/202307:00EDGAR2Form 8-K - Current report
10/26/202307:00PRNUSBlueprint Medicines Reports Third Quarter 2023 Results
10/23/202308:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
10/12/202308:00PRNUSBlueprint Medicines to Report Third Quarter 2023 Financial..
10/05/202316:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
10/05/202310:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/29/202314:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202316:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
8/28/202318:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/25/202308:15EDGAR2Form 8-K - Current report
8/24/202316:21EDGAR2Form 144 - Report of proposed sale of securities
8/04/202316:16PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
8/02/202316:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/202307:00EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock